
    dosing stopped
  
['duchenne muscular dystrophy']
['ht-100']

        Inclusion Criteria:

          1. Completed both previous studies HALO-DMD-01 and HALO-DMD-02

          2. Ability to provide written informed consent

          3. Ability to understand and follow site and protocol instruction for the entire duration
             of the study

        Exclusion Criteria:

        Answering yes to any of the following make the subject NOT eligible to participate in the
        study.

          1. Clinically significant major disease not related to DMD that would make it not safe to
             be in the study or affect ability to follow the protocol

          2. History of severe allergic or anaphylactic reactions

          3. Recent report of drug/alcohol abuse
      